Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
Could Weight-Loss Drugs Help Get People Back to Work? The U.K. Wants to Find Out.
The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...
Britain to study use of Lilly's weight loss drug to get people back to work
Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...
Why weight-loss drugs may be no obesity silver bullet
Wegovy, the brand name for semaglutide, is only available as a weight-loss drug for people who are severely obese and living ...
News Nation on MSN4d
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
STAT7d
As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
This trust offers an investment cure as weight-loss wonder drugs’ side effects mount
Questor is The Telegraph’s stockpicking column, helping you decode the markets and offering insights on where to invest for ...
Weight-loss drugs: How much should investors worry about side effects?
Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
Mounjaro will soon be available as a weight loss treatment on the NHS. Here's what that means for patients
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...
AOL14d
What end of Eli Lilly's weight-loss drug shortage means for the competition
The US Food and Drug Administration confirmed Thursday that Eli Lilly (LLY) has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the ...